宏力医疗管理发布中期业绩 股东应占亏损67.3万元 同比盈转亏

Group 1 - The core viewpoint of the article is that Macro Medical Management (09906) reported a significant decline in its mid-year performance for 2025, with a revenue of 347 million RMB, representing a year-on-year decrease of 16.5% [1] - The company experienced a loss attributable to shareholders of 673,000 RMB, contrasting with a profit of 20.04 million RMB in the same period last year, indicating a shift from profit to loss [1]